These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2864848)

  • 1. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
    Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
    Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
    Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic pharmacology of esmolol.
    Gorczynski RJ
    Am J Cardiol; 1985 Oct; 56(11):3F-13F. PubMed ID: 2864846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative use of esmolol.
    Reves JG; Flezzani P
    Am J Cardiol; 1985 Oct; 56(11):57F-62F. PubMed ID: 2864850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and pharmacokinetics of esmolol.
    Reynolds RD; Gorczynski RJ; Quon CY
    J Clin Pharmacol; 1986 Mar; 26(S1):A3-A14. PubMed ID: 2870084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
    Viray R; Turlapaty P; Laddu A
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
    Reimer KA; Jennings RB
    Am J Cardiol; 1985 Jan; 55(3):107B-115B. PubMed ID: 3881903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model.
    Laub GW; Muralidharan S; Reibman J; Fernandez J; Anderson WA; Gu J; Daloisio C; McGrath LB; Mulligan LJ
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1085-91. PubMed ID: 8622306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
    Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
    J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiology of esmolol.
    Greenspan AM; Spielman SR; Horowitz LN; Senior S; Steck J; Laddu A
    Am J Cardiol; 1985 Oct; 56(11):19F-26F. PubMed ID: 2864844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs.
    Lange R; Kloner RA; Braunwald E
    Am J Cardiol; 1983 Jun; 51(10):1759-67. PubMed ID: 6134464
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with beta-blockers in patients with acute coronary syndrome].
    Nozawa T; Inoue H
    Nihon Rinsho; 1998 Oct; 56(10):2612-6. PubMed ID: 9796327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
    Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
    Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
    Willerson JT; Buja LM
    Am J Cardiol; 1984 Dec; 54(11):16E-20E. PubMed ID: 6150632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.